# Pharmacology of Cognition in Schizotypal Personality Disorder

> **NCT00353379** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 29 (actual)

## Conditions studied

- Schizotypal Personality Disorder
- Personality Disorders

## Interventions

- **DRUG:** Guanfacine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00353379
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1995-09
- **Primary completion:** 1997-05
- **Final completion:** 1997-05
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2017-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00353379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00353379, "Pharmacology of Cognition in Schizotypal Personality Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00353379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*